CHOONG ANG VACCINE LABORATORY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,830 KRW | -0.73% |
|
-0.18% | -1.63% |
| May. 10 | Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares. | CI |
| May. 10 | Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan. | CI |
| Sales 2021 | 40.91B 29.74M | Sales 2022 | 39.3B 28.57M | Capitalization | 107B 78.04M |
|---|---|---|---|---|---|
| Net income 2021 | 7.6B 5.53M | Net income 2022 | 4.04B 2.94M | EV / Sales 2021 | 3.38 x |
| Net cash position 2021 | 9.58B 6.96M | Net cash position 2022 | 5.44B 3.96M | EV / Sales 2022 | 2.59 x |
| P/E ratio 2021 |
19.4
x | P/E ratio 2022 |
26.5
x | Employees | 167 |
| Yield 2021 |
0.67% | Yield 2022 |
0.91% | Free-Float | 65.5% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.73% | ||
| 1 week | -0.18% | ||
| Current month | +1.40% | ||
| 1 month | +1.12% | ||
| 3 months | +2.56% | ||
| 6 months | -1.99% | ||
| Current year | -1.63% |
1 week
10 810.00
11 060.00
1 month
10 600.0011 480.00
Current year
10 380.0011 630.00
1 year
9 960.0015 400.00
3 years
9 830.0018 300.00
5 years
9 830.0023 850.00
10 years
9 830.0034 708.33
| Managers | Title | Age | Since |
|---|---|---|---|
In-Joong Yoon
CEO | Chief Executive Officer | 61 | - |
Ju-Yong Lee
PSD | President | 51 | - |
Seong-Sik Yoo
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-02-22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
In-Joong Yoon
CEO | Chief Executive Officer | 61 | - |
Seong-Sik Yoo
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-02-22 |
Ju-Yong Lee
PSD | President | 51 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-11 | 10,830 | -0.73% | 27,544 |
| 24-07-10 | 10,910 | +0.18% | 32,161 |
| 24-07-09 | 10,890 | -0.55% | 33,276 |
| 24-07-08 | 10,950 | +0.92% | 98,300 |
| 24-07-05 | 10,850 | 0.00% | 50,760 |
End-of-day quote Korea S.E., July 10, 2024
More quotes
Choong Ang Vaccine Laboratory Co., Ltd. is a Korea-based company mainly engaged in the manufacturing and marketing of veterinary vaccines. The Company provides veterinary vaccines for fowl, dogs, pigs, cattle, rabbits, cats, fishes and others under the brand name SuiShot, PoulShot, Canishot, BoviShot, FeliShot, RabbiShot and AquaShot. The Company also provides diagnosis services, and distributes other veterinary drugs, such as antibiotics, anthelmintics, disinfectants and feed additives. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.63% | 76.21M | |
| -9.95% | 79.16B | |
| +26.88% | 3.63B | |
| -4.31% | 3.17B | |
| +22.64% | 1.72B | |
| -5.86% | 1.22B | |
| -36.77% | 1.01B | |
| -41.57% | 936M | |
| -17.88% | 830M | |
| -34.79% | 825M |
- Stock Market
- Equities
- A072020 Stock
